Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Joined May 2012
5 Photos and videos Photos and videos

Tweets

You blocked @AblynxABLX

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @AblynxABLX

  1. Retweeted
    Jul 26

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 retweets 4 likes
  2. Retweeted
    Jul 20

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 retweets 7 likes
  3. Jul 19

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 reply 9 retweets 14 likes
  4. Jun 26

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 retweets 16 likes
  5. Jun 25

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 retweets 6 likes
  6. May 29

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 retweets 9 likes
  7. May 21

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 retweets 12 likes
  8. May 18

    Meet our experts and recruiters (booth 99) @

    2 likes
  9. May 11

    Ablynx zit op schema via

    4 retweets 6 likes
  10. May 10

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 retweets 4 likes
  11. May 10

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 retweets 7 likes
  12. May 2

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 retweets 6 likes
  13. Apr 7

    Annual Report 2016 is available online - view via

    1 retweet 4 likes
  14. Apr 7

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 retweet 4 likes
  15. Retweeted
    Mar 6

    Compelling data for developed psoriasis nanobody in collaboration

    3 retweets 2 likes
  16. Retweeted
    Feb 28

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 replies 51 retweets 103 likes
  17. Retweeted
    Feb 24

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 retweet 1 like
  18. Feb 22

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 retweets 3 likes
  19. Feb 9

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 retweets 2 likes
  20. Feb 6

    Ablynx files caplacizumab for ultra rare blood disorder
    6 retweets 9 likes

@AblynxABLX hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·